Responses
Electronic pages
Correspondence response
eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese
Compose a Response to This Article
Other responses
No responses have been published for this article.